Most marijuana stock investors are keeping a core focus on the future. At one point in time, most cannabis stocks had fast turnarounds for making a profit. However, this has not been the case for a long while. In fact, since the pandemic, there has been an overwhelming drop in trading in that sector. Now, with a bigger push for federal reform and other rules and regulatory issues being worked o...
The U.S. cannabis industry is gaining momentum again, and ancillary stocks are attracting investor attention this week. The legal market generated over $30 billion in sales last year and could exceed $50 billion by 2030. Ancillary companies provide vital tools, marketplaces, and supplies, making them less exposed to direct regulation. Recent headlines highlight renewed discussions in Congress a...
The U.S. cannabis industry continues to expand, with annual sales expected to surpass 40 billion dollars in 2025. Market forecasts suggest long-term growth as more states approve medical and recreational use. Recent discussions on federal legalization have also reignited investor interest. These developments provide a favorable backdrop for ancillary companies, which support the industry withou...
For cannabis investors, watching the industry's growth brings hope. Especially with how volatile the sector can get, even when public companies do well as a business, it does not resonate in the stock market. In recent news, Q2 earnings have been released for most publicly traded cannabis companies. Some companies have reported that they are still generating decent revenue. For others, beyond s...
I recommend a modest BUY position in GrowGeneration, leveraging a covered call strategy for enhanced returns with limited risk. The near-term call option sale offers a 5.8% return in 39 days, annualizing to 54.7%, with strong liquidity in GRWG options. Upside for GrowGeneration hinges on cannabis rescheduling and removal of 280E taxation, which would benefit its core customers.
Marijuana stock investors are awaiting to hear what will come of cannabis rescheduling. Historically, when news on the matter is released that shows progress, most cannabis stocks begin to trade up. This is what speculation can do. No one wants to be late to invest or miss the chance to be in an emerging sector. Legal cannabis has been on the rise for many years. Facing many roadblocks and stil...
The U.S. cannabis industry continues to expand rapidly, making ancillary stocks an attractive area for investors. In 2024, legal cannabis sales reached more than $29 billion nationwide. Analysts project the market could surpass $45 billion by 2030 as legalization spreads. Ancillary companies supply the technology, data, and cultivation tools that dispensaries and growers need to operate efficie...
Collaboration will greatly expand GrowGen's market reach for organic fertilizers, propagation systems, and sustainable growing media across Arett's 32-state lawn & garden network Collaboration will greatly expand GrowGen's market reach for organic fertilizers, propagation systems, and sustainable growing media across Arett's 32-state lawn & garden network
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.